357.66
  Price2.10%   -7.67
(Pre-market: 361.91 +4.25 +1.19%)
Nov-24-21 11:30AM 10x Genomics Stock: Bull vs. BearThe Motley Fool
Nov-23-21 08:07AM Don't Squander Your Income on These 3 Toxic StocksZacks Investment Research
07:54AM Illumina's (ILMN) New Alliance to Accelerate Genomics in ChinaZacks Investment Research
Nov-18-21 06:00AM Top Buys From The Best Money Managers (Q3 2021)Seeking Alpha
Nov-17-21 09:26AM Illumina (ILMN) iHope Genetic Health Program Expands WGS AccessZacks Investment Research
Nov-08-21 06:20AM Should You Invest in the VanEck Biotech ETF (BBH)?Zacks Investment Research
Nov-05-21 07:52AM Illumina (ILMN) Q3 Earnings Top Estimates, 2021 Revenue View UpZacks Investment Research
Nov-04-21 11:02AM Illumina, inc (ILMN) Q3 2021 Earnings Call TranscriptThe Motley Fool
08:14AM The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPOBenzinga
Nov-03-21 11:40AM EXEL vs. ILMN: Which Stock Is the Better Value Option?Zacks Investment Research
Oct-19-21 10:02AM New Strong Sell Stocks for October 19thZacks Investment Research
Sep-18-21 07:05AM The 1 Stock I'd Buy Right NowThe Motley Fool
Sep-15-21 06:20AM Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?Zacks Investment Research
Sep-14-21 09:05AM 3 Crash-Ready Stocks to Buy in SeptemberThe Motley Fool
Sep-13-21 02:56AM UK's NHS Launches World's Largest Trial Of Blood Test For 50 TypesBenzinga
Sep-04-21 09:55AM Why Illumina Wants Grail Back So BadlyThe Motley Fool
Aug-30-21 04:00AM Tracking Ron Baron's BAMCO Portfolio - Q2 2021 UpdateSeeking Alpha
Aug-27-21 04:13AM Workday And Lam Research Lead The QQQBenzinga
Aug-26-21 11:32AM Illumina (ILMN), Grail Merger Sees Futher Regulatory ChallengesZacks Investment Research
Aug-23-21 01:48AM Illumina (ILMN) Shares Slip on GRAIL Buyout Deal CompletionZacks Investment Research
Aug-19-21 04:55AM Microsoft And Cisco Gain As The QQQ Bounces Back ThursdayBenzinga
03:56AM Why Illumina Stock Just Dropped 10%The Motley Fool
Aug-19-21 07:37AM The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With MerckBenzinga
Aug-14-21 08:12AM Illumina Delivers a Beat and a Raise in Q2The Motley Fool
Aug-11-21 06:22AM Forget Robinhood, These 3 Healthcare Stocks Are Better BuysThe Motley Fool
06:00AM What Does the Future Look Like for Illumina Stock?The Motley Fool
Aug-08-21 05:00AM Why Does Illumina Want to Reunite With Grail?The Motley Fool
Aug-06-21 04:12AM Tesla And eBay Fall As The QQQ Closes LowerBenzinga
12:45PM Looking for a Growth Stock? 3 Reasons Why Illumina (ILMN) is a Solid ChoiceZacks Investment Research
Aug-06-21 10:07AM Illumina (ILMN) Q2 Earnings Top Estimates, 2021 View UpZacks Investment Research
07:55AM Illumina Q2 Earnings Boosted By Robust Growth In Core Sequencing Business; Uplifts FY21 OutlookBenzinga
Aug-06-21 06:20AM Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?Zacks Investment Research
Aug-05-21 11:01AM Illumina, inc (ILMN) Q2 2021 Earnings Call TranscriptThe Motley Fool
Aug-04-21 11:57AM Why Zymergen Stock Is Plunging 76% TodayThe Motley Fool
10:39AM Drug/Biotech Stocks Q2 Earnings Due on Aug 5: REGN, MRNA, ZTS, ILMNZacks Investment Research
Aug-04-21 08:40AM Fresh off IPO, ‘biofacturing’ company Zymergen’s stock plunges about 70% after some really bad newsMarketWatch
06:45AM $5,000 Invested in These 3 Healthcare Stocks Could Make You Rich Over the Next 10 YearsThe Motley Fool
Aug-03-21 06:16AM Fresh off IPO, ‘biofacturing’ company Zymergen’s stock plunges about 70% after some really bad newsMarketWatch
05:24AM Fresh off IPO, ‘biofacturing’ company Zymergen’s stock plunges more than 70% after some really bad newsMarketWatch
Aug-03-21 01:22AM AMN Healthcare (AMN) to Report Q2 Earnings: What to Expect?Zacks Investment Research
12:30PM Quidel (QDEL) to Report Q2 Earnings: What's in the Offing?Zacks Investment Research
Aug-03-21 10:35AM What's in Store for Fulgent Genetics (FLGT) in Q2 Earnings?Zacks Investment Research
Aug-02-21 10:24AM BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?Zacks Investment Research
09:45AM Is a Beat in Store for Zoetis (ZTS) This Earnings Season?Zacks Investment Research
Aug-02-21 09:29AM Editas (EDIT) to Report Q2 Earnings: What's in the Cards?Zacks Investment Research
08:10AM Canopy Growth (CGC) to Report in Q1 Earnings: What's in Store?Zacks Investment Research
Jul-30-21 11:29AM Is a Beat in the Cards for CVS Health (CVS) in Q2 Earnings?Zacks Investment Research
06:35AM 3 Things About Illumina That Smart Investors KnowThe Motley Fool
Jul-29-21 03:05AM Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's ReleaseZacks Investment Research
12:39PM Abiomed (ABMD) to Report Q1 Earnings: What's in the Cards?Zacks Investment Research
Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company operates in two segments, Core Illumina and Consolidated VIEs. It offers sequencing by synthesis technology that provides researchers with various applications and the ability to sequence mammalian genomes; and arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow the detection of known genetic markers on a single array. The company also provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and noninvasive prenatal testing, as well as products support services. It serves genomic research centers, academic institutions, government laboratories, and hospitals; and pharmaceutical, biotechnology, agrigenomics, and commercial molecular diagnostic laboratories, as well as consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. It operates in North America, Europe, Latin America, the Asia-Pacific region, the Middle East, and South Africa. The company has a strategic partnership with Loxo Oncology, Inc. to develop and commercialize a multi-gene panel for broad tumor profiling; and strategic collaboration with Bristol-Myers Squibb Company. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Cap:    |  Volume (24h):